Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04015726
Recruitment Status : Not yet recruiting
First Posted : July 11, 2019
Last Update Posted : July 15, 2019
Sponsor:
Information provided by (Responsible Party):
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals

Brief Summary:
The prevalence of cardiometabolic risk is high among South Asians which manifests itself at an early age. Studies have reported that unhealthy food choices, inadequate physical activity and lack of awareness on healthy lifestyle practices pose a huge threat to the increasing prevalence of metabolic abnormalities even at adolescence. In an earlier study conducted in 2006, reported that 68% of the children during their early adolescence had one or more of the cardiometabolic abnormalities such as obesity, central adiposity, increased blood pressure and presence of dysglycaemia and dyslipidaemia. The risk escalated with increasing weight. Therefore, it is imperative to sensitize the children on improving their lifestyle by conducting screening tests and health education programmes in schools by involving teachers. The Investigator have also shown in a study that teachers can be instrumental in imparting knowledge on the prevention of non-communicable diseases such as diabetes by promoting healthy behavioral changes. The proposed study will focus on a) changes in the prevalence of cardiometabolic risk factors over a 10 year period b) health education programme to school children c) recommendations to school teachers (tool-kit) to inculcate improved lifestyle practices to their students.

Condition or disease
Obesity Dysglycemia Dyslipidemias Hypertension Insulin Resistance

Detailed Description:

This programme will be conducted after obtaining prior permission from the Directorate of School Education, Government of Tamil Nadu and school authorities. This study will be conducted in 22 schools in Chennai involving 2815 students of age group 12 to 18 years. Initially the study and its procedure will be explained to the principal and the teachers of the school. Request the school authority to fix a date for each standard/grade to explain about the informed consent / assent form and the study process to the students. The students will be asked to give the informed consent/assent form to their parents and asked to get their signature in the specified place. Instruction will be given to the students that their parents can call the Investigator if they have any doubts in the informed consent/assent form. After giving ample time for the informed consent process the students will be asked to give the informed consent when the research team goes to the school. The informed consent should be countersigned by the teachers to confirm the authenticity of the parent's signature. The research team gets the signature from the student in the assent form. A date is finalized with the school authority for the screening. The students are advised to come in fasting for the test. On the day of screening the student will be given a screening number. Necessary details such as personal and family information, anthropometry (height, weight, waist circumference, body fat) and blood pressure will be measured. Medical history, diet, physical activity, and sleep habits and questionnaire on awareness on diabetes will be recorded. Laboratory investigations such as fasting blood glucose, plasma insulin and lipid profile (Total Cholesterol, Triglyceride, Low-Density Lipoprotein (LDL), Very Low-Density Lipoprotein (VLDL) and High-Density Lipoprotein (HDL)) will be measured.

After the assessment, the students will be given refreshments and a few minutes of rest. The samples will be sent to the central laboratory for analyses. The reports will be distributed to the students within a week's time. Parents will be personally contacted by the research team if there is any concern in the lab report which requires medical attention.


Layout table for study information
Study Type : Observational
Estimated Enrollment : 2815 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India
Estimated Study Start Date : August 1, 2019
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : December 31, 2020



Primary Outcome Measures :
  1. Prevalence of central adiposity [ Time Frame: baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  2. Prevalence of dysglycemia [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  3. Prevalence of dyslipidemia [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  4. Prevalence of hypertension [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  5. Prevalence of insulin resistance [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data


Secondary Outcome Measures :
  1. Prevalence of overweight [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  2. Prevalence of obesity [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  3. Changes in diet habit [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data

  4. Changes in duration of physical activity [ Time Frame: Baseline ]
    Among adolescent children in 2019 in comparison with 2006 data



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Children both boys and girls between 12 - 18yrs age group
Criteria

Inclusion Criteria:

  1. Children both boys and girls between 12 - 18yrs age group
  2. Parents and child willing to give informed consent
  3. Children must be available for and willing to attend all evaluation visits
  4. Willingness to follow the protocol requirements as evidenced by written informed consent

Exclusion Criteria:

  1. Children below the age of 12 years and above the age of 18 years
  2. Parents or Child who is not willing to participate in the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04015726


Contacts
Layout table for location contacts
Contact: Ambady Ramachandran, MD, PhD, DSc 04422353730 research@ardiabetes.org

Locations
Layout table for location information
India
India Diabetes Research Foundation Not yet recruiting
Chennai, Tamil Nadu, India, 600008
Contact: Ambady Ramachandran, MD, PhD, DSc         
Principal Investigator: Ambady Ramachandran, MD, PhD, DSc         
Sponsors and Collaborators
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Investigators
Layout table for investigator information
Principal Investigator: Ambady Ramachandran, MD, PhD, DSc Senior Research Officer

Layout table for additonal information
Responsible Party: India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
ClinicalTrials.gov Identifier: NCT04015726     History of Changes
Other Study ID Numbers: IDRFARH012
First Posted: July 11, 2019    Key Record Dates
Last Update Posted: July 15, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Insulin Resistance
Dyslipidemias
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Lipid Metabolism Disorders